Boston Scientific Adds More Non-Vascular Stents To MedSurg Business With MI Tech Acquisition
Executive Summary
Boston Scientific will pay about $230m for 64% of Korea-based MI Tech, which developed the Hanarostent line of conformable, self-expanding metal stents for endoscopic and urologic applications.
You may also be interested in...
Boston Scientific Picks Up Pancreatic Stent Maker Xlumena
In the $62.5 million-plus-milestone deal Boston Scientific gets Xlumena's Axios and Hot Axios stent and delivery systems for endoscopic ultrasound-guided transluminal drainage of symptomatic pancreatic pseudocysts. The products fit alongside Boston's Expect endoscopic ultrasound aspiration needles.
Minute Insight: Abbott Plans Move Into Famous Chicago Skyscraper
Local newspapers in Chicago confirm that Abbott is leasing space in Chicago’s most famous building in an attempt to better serve employees who live closer to the city than its Lake County, IL, campus.
Abbott Announces Another Health Equity Initiative
The Abbott Fund, the company’s charitable foundation, has granted Easterseals $750,000 to fund a three-year pilot project supporting education and community health equity.